Pharmaco-invasive approach next best to PCI: study
A meta-analysis shows first-line fibrinolysis benefits patients with STEMI without immediate access to PCI
Fibrinolysis is the best first option for patients presenting to hospitals with ST-segment elevation myocardial infarction (STEMI) in cases where immediate percutaneous coronary intervention (PCI) is not available, researchers say.
The intervention should be followed by PCI between two and 24 hours later, they say.
The findings should help with treatment decisions for rural patients and others without easy access to a hospital providing PCI.
The US-led network
